Xun, Xu,,
Liang, Yuan,
Gareev, Ilgiz,
Liang, Yanchao,
Liu, Rui,
Wang, Ning,
Yang, Guang (2023) and chemoradiotherapy resistance, we discussed the feasibility for lncRNAs as
therapeutic targets. Finally
attention in this context. They emerge as pivotal biomarkers and potential
therapeutic targets, offering
Beilerli, A.,
Gareev, I.,
Beylerli, O.,
Yang, G.,
V.N. Pavlov,
Aliev, G.,
Ahmad, A. (2022) discuss the possibility of using circRNAs as potential
therapeutic targets and biomarkers for cancer.
MicroRNAs as prognostic markers and
therapeutic targets in gliomas
current knowledge on promising lncRNAs as biomarkers and
therapeutic targets for IS exploring original
Begliarzade, Sema,
Beilerli, Aferin,
Sufianov, Albert,
Tamrazov, Rasim,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Liang, Yanchao,
Beylerli, Ozal (2023) tools, as well as to consider them as effective
therapeutic targets in cervical cancer.
formation and their consideration as
therapeutic targets have been well studied. In this case, accurate
the
therapeutic possibilities for pituitary adenomas.
for personalized medicine and
targeted therapeutic interventions. © 2024 Elsevier B.V.
Usman, M.,
Beilerli, A.,
Sufianov, A.,
Kudryashov, V.,
Ilyasova, T.,
Balaev, P.,
Danilov, A.,
Lu, H.,
Gareev, I. (2023) (lncRNAs) and circular
RNAs (circRNAs) into clinical medicine as biomarkers and
therapeutic targets.